BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gschwandtner E, Klatte T, Swietek N, Bures C, Kober F, Ott J, Schultheis A, Neuhold N, Hermann M. Increase of papillary thyroid microcarcinoma and a plea for restrictive treatment: A retrospective study of 1,391 prospective documented patients. Surgery 2016;159:503-11. [PMID: 26189948 DOI: 10.1016/j.surg.2015.06.015] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
Number Citing Articles
1 Jin S, Bao W, Yang YT, Fu Q, Bai Y, Liu Y. Proteomic analysis of the papillary thyroid microcarcinoma. Ann Endocrinol (Paris) 2019;80:293-300. [PMID: 31606199 DOI: 10.1016/j.ando.2019.01.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
2 Hermann M, Gschwandtner E, Schneider M, Handgriff L, Prommegger R. [Modern thyroid surgery - the surgeon's endocrine-surgical understanding and his responsibility for the extent of surgery and complication rate]. Wien Med Wochenschr 2020;170:379-91. [PMID: 32342248 DOI: 10.1007/s10354-020-00750-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Lin P, Yao Z, Sun Y, Li W, Liu Y, Liang K, Liu Y, Qin J, Hou X, Chen L. Deciphering novel biomarkers of lymph node metastasis of thyroid papillary microcarcinoma using proteomic analysis of ultrasound-guided fine-needle aspiration biopsy samples. J Proteomics 2019;204:103414. [PMID: 31195151 DOI: 10.1016/j.jprot.2019.103414] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
4 Kurtaran A, Schmoll-hauer B, Tugendsam C. Aktuelle Diskussion zur risikoadaptierten Therapie des differenzierten Schilddrüsenkarzinoms: Ist weniger (Therapie) wirklich mehr? Wien Med Wochenschr 2020;170:15-25. [DOI: 10.1007/s10354-019-00713-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Murthy SP, Balasubramanian D, Anand A, Limbachiya SV, Subramaniam N, Nair V, Thankappan K, Iyer S. Extent of Thyroidectomy in Differentiated Thyroid Cancers-Review of Evidence. Indian J Surg Oncol 2018;9:90-6. [PMID: 29563745 DOI: 10.1007/s13193-017-0661-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
6 Liu C, Zhang L, Liu Y, Xia Y, Cao Y, Liu Z, Chen G, Liu N, Shang Z, Yang J, Sun Q, Li X. Ultrasonography for the Prediction of High-Volume Lymph Node Metastases in Papillary Thyroid Carcinoma: Should Surgeons Believe Ultrasound Results? World J Surg 2020;44:4142-8. [PMID: 32918103 DOI: 10.1007/s00268-020-05755-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Kaliszewski K, Wojtczak B, Strutyńska-Karpińska M, Łukieńczuk T, Forkasiewicz Z, Domosławski P. Incidental and non-incidental thyroid microcarcinoma. Oncol Lett 2016;12:734-40. [PMID: 27347209 DOI: 10.3892/ol.2016.4640] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
8 Gürleyik E, Gurleyik G, Karapolat B, Onsal U. Incidental Papillary Thyroid Microcarcinoma in an Endemic Goiter Area. J Thyroid Res 2016;2016:1784397. [PMID: 26949559 DOI: 10.1155/2016/1784397] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
9 Liu C, Liu Y, Zhang L, Dong Y, Hu S, Xia Y, Zhang B, Cao Y, Liu Z, Chen G, Shang Z, Yang J, Sun Q, Li X. Risk factors for high-volume lymph node metastases in cN0 papillary thyroid microcarcinoma. Gland Surg 2019;8:550-6. [PMID: 31741886 DOI: 10.21037/gs.2019.10.04] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
10 Weber T, Peth S, Hummel R. [Surgery of papillary thyroid microcarcinoma]. Chirurg 2018;89:415-21. [PMID: 29305632 DOI: 10.1007/s00104-017-0571-4] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Weber T. [Current treatment strategies for papillary thyroid microcarcinoma]. Chirurg 2020;91:994-8. [PMID: 32776249 DOI: 10.1007/s00104-020-01263-y] [Reference Citation Analysis]
12 Malaguarnera R, Vella V, Nicolosi ML, Belfiore A. Insulin Resistance: Any Role in the Changing Epidemiology of Thyroid Cancer? Front Endocrinol (Lausanne) 2017;8:314. [PMID: 29184536 DOI: 10.3389/fendo.2017.00314] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
13 Tunca F, Sormaz İC, İşcan AY, Şenyürek YG. Surgical Treatment in Papillary Thyroid Microcarcinoma. Sisli Etfal Hastan Tip Bul 2018;52:244-8. [PMID: 32774085 DOI: 10.14744/SEMB.2018.45452] [Reference Citation Analysis]
14 Yi D, Song P, Huang T, Tang X, Sang J. A meta-analysis on the effect of operation modes on the recurrence of papillary thyroid microcarcinoma. Oncotarget 2017;8:7148-56. [PMID: 27756889 DOI: 10.18632/oncotarget.12698] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
15 Ruiz J, Ríos A, Rodríguez JM, Paredes M, Soriano V, Oviedo MI, Hernández AM, Parrilla P. Incidental versus clinical diagnosis of papillary thyroid microcarcinoma. Long-term prognosis. Endocrinol Diabetes Nutr (Engl Ed) 2020;67:317-25. [PMID: 31882257 DOI: 10.1016/j.endinu.2019.09.012] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
16 Huang K, Gao N, Bian D, Zhai Q, Yang P, Zhang Y. Associations of BRAF V600E, clinical pathology and imaging factors with the recurrence rate of papillary thyroid microcarcinoma. Exp Ther Med 2020;20:243. [PMID: 33178341 DOI: 10.3892/etm.2020.9373] [Reference Citation Analysis]
17 Ding Z, Ke R, Zhang Y, Fan Y, Fan J. FOXE1 inhibits cell proliferation, migration and invasion of papillary thyroid cancer by regulating PDGFA. Mol Cell Endocrinol 2019;493:110420. [PMID: 31129275 DOI: 10.1016/j.mce.2019.03.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
18 Xue S, Wang P, Hurst ZA, Chang YS, Chen G. Active Surveillance for Papillary Thyroid Microcarcinoma: Challenges and Prospects. Front Endocrinol (Lausanne) 2018;9:736. [PMID: 30619082 DOI: 10.3389/fendo.2018.00736] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]